Interferon plus ribavirin in patients with hepatitis C virus positive mixed cryoglobulinemia resistant to interferon

Journal of Rheumatology

Volumn 30, Issue 8, 2003, Pages 1775-1781

  Mazzaro, Cesare ^b   Zorat, Francesca ^b   Comar, Consuelo ^b   Nascimben, Fabiana ^b   Bianchini, Dario ^b   Baracetti, Stefano ^b   Donada, Carlo ^b   Donadon, Valter ^b   Pozzato, Gabriele ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b NONE

Author keywords

Interferon; Hepatitis C virus; Mixed cryoglobulinemia; Non Hodgkin's lymphoma; Ribavirin

Indexed keywords

ALANINE AMINOTRANSFERASE; COMPLEMENT; CRYOGLOBULIN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARACETAMOL; PARAPROTEIN; RECOMBINANT ALPHA2B INTERFERON; RHEUMATOID FACTOR; RIBAVIRIN; VIRUS RNA;

ADULT; ANEMIA; ARTICLE; BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOGLOBULINEMIA; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; FATIGUE; FEMALE; FEVER; FLOW CYTOMETRY; FLU LIKE SYNDROME; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; NEPHELOMETRY; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTOPENIA;

ADULT; ANTIVIRAL AGENTS; BIOPSY; COMPLEMENTARITY DETERMINING REGIONS; CRYOGLOBULINEMIA; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; RECURRENCE; RIBAVIRIN; TREATMENT OUTCOME;

EID: 0043031300     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Grey HM, Kohler PF. Cryoglobulins. Semin Hematol 1973;10:87-96.
2. Disdier P, Harl JR, Weiller PJ. Cryoglobulinemia and hepatic infection. Lancet 1991;338:1151-3.
3. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-5.
4. Ferri C, Greco F, Longobardo G, et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin Exp Rheumatol 1991;9:621-4.
5. Pascual M, Perrin L, Giostra E, Schifferli JA. Hepatitis C virus in patients with cryoglobulinemia type II. J Infect Dis 1990;162:569-70.
6. Johnson RJ, Gretch DR, Couser WG, et al. Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int 1994;46:1700-4.
7. Misiani R, Vicari O, Bellavita PM, Sonzogni A, Marin MG. Hepatitis C virus in renal tissue of patients with glomerulonephritis [letter]. Nephron 1994;68:400.
8. Pozzato G, Mazzaro C, Crovatto M, et al. Low-grade malignant lymphoma, hepatitis C virus infection and mixed cryoglobulinemia. Blood 1994;84:3047-53.
9. Mazzaro C, Zagonel V, Monfardini S, et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996;92:1275-9.
10. Ferri C, Pietrogrande M, Cecchetti R, et al. Low antigen content diet in the treatment of mixed cryoglobulinemia patients. Am J Med 1989;87:519-24.
11. Vacca A, Dammacco E Deflazacort versus prednisone in the treatment of EMC: a controlled clinical study. Int Arch Allergy Appl Immunol 1992;99:306-13.
12. Ballare M, Bobbio F, Poggi S, et al. A pilot study on the effectiveness of cyclosporine in type II mixed cryoglobulinemia. Clin Exp Rheumatol 1995;13 Suppl 13:201-3.
13. Monti G, Saccardo F, Rinaldi G, Petrozzino MR, Gomitoni A, Invernizzi F. Colchicine in the treatment of mixed cryoglobulinemia. Clin Exp Rheumatol 1995;13 Suppl 13:197-9.
14. Ferri C, Gremignai G, Bombardieri S, et al. Plasma exchange in mixed cryoglobulinemia: The effect on renal, liver and neurologic involvement. La Ricerca in Clinica e in Laboratorio 1986;16:403-11.
15. Tavoni A, Mosca M, Ferri C, et al. Guidelines for the management of essential mixed cryoglobulinemia. Clin Exp Rheumatol 1995;13 Suppl 13:191-5.
16. Mazzaro C, Pozzato G, Moretti M, et al. Long-term effects of alpha interferon therapy for type II mixed cryoglobulinemia. Haematologica 1994;79:342-9.
17. Yamabe H, Johnson RJ, Gretch DR, Osawa H, Inuma H, Sasaki T. Membrano-proliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon alpha. Am J Kidney Dis 1995;25:67-9.
18. Mazzaro C, Lacchin T, Moretti M, et al. Effects of two different alpha-interferon regimens on clinical and virological findings in mixed cryoglobulinemia. Clin Exp Rheumatol 1995;13 Suppl 13:180-5.
19. De Rosa FG, Di Lullo L, Coviello R, Donanno S, Laganà B, Casato M. Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia [letter]. J Hepatol 1998;28:335-9.
20. Willson RA. The benefit of long-term interferon alfa therapy for symptomatic mixed cryoglobulinemia (cutaneous vasculitis/membranoproliferative glomerulonephritis) associated with chronic hepatitis C. J Clin Gastroenterol 2001;33:137-40.
21. Laganovich M, Jelakovic B, Kuzmanic D, et al. Complete remission of cryoglobulinemic glomerulonephritis (HCV-positive) after high-dose interferon therapy. Wien Klin Wochenschr 2000;112:596-600.
22. Casato M, Laganà B, Pucillo LP, Quinti I. Interferon for hepatitis C virus-negative type II mixed cryoglobulinemia [letter]. N Engl J Med 1998;338:1386-7.
23. Mazzaro C, Carniello GS, Doretto P, et al. Interferon therapy in HCV-positive mixed cryoglobulinemia: viral and host factors contributing to efficacy of the therapy. It J Gastroenterol Hepatol 1997;29:343-7.
24. Alberti A, Chemello L, Noverta F, Cavalletto L, De Salvo G, Retreatment with interferon. Hepatology 1997;26 Suppl 3:1375-425.
25. Heathcote EJL, Keeffe EB, Lee SS, et al. Re-treatment of chronic hepatitis C with consensus interferon. Hepatology 1998;27:1136-43.
26. Gaeta GB, Di Virgilio D, Russo G, et al. Human leukocyte interferon-α in chronic hepatitis C resistant to recombinant or lymphoblastoid interferon-α: a randomised controlled trial. J Viral Hepatol 1997;4:209-14.
27. Carrara C, Azzurro M, Adamo S. Retreatment with human leukocyte interferon alpha of chronic hepatitis C recurring after a first cycle with recombinant interferon [letter]. It J Gastroenterol Hepatol 1998;30:234-5.
28. Simon DM, Gordon SC, Kaplan MM, et al. Treatment of chronic hepatitis C with interferon alfa-n3: a multicenter, randomized, open-label trial. Hepatology 1997;25:445-8.
29. Cacopardo B, Benanti F, Brancati G, Romano F, Nunnari A. Leukocyte interferon-alpha retreatment for chronic hepatitis C patients previously intolerant to other interferons. J Viral Hepatol 1998;5:333-9.
30. Mazzaro C, Colle R, Baracetti S, Nascimben F, Zorat F, Pozzato G. Effectiveness of leukocyte interferon in patients affected by HCV-positive mixed cryoglobulinemia resistant to recombinant alpha-interferon. Clin Exp Rheumatol 2002;20:17-24.
31. Andreone P, Gramenzi AG, Cursaro C, et al. Interferon plus ribavirin in chronic hepatitis C resistant to previous interferon course: results of a randomised multicenter trial. J Hepatol 1999;30:788-93.
32. Teuber G, Berg T, Hoffman RM, et al. Retreatment with interferon-alpha and ribavirin in primary interferon non-responders with chronic hepatitis C. Digestion 2000;61:90-7.
33. Min AD, Jones JL, Esposito S, et al. Efficacy of high-dose interferon in combination with ribavirin in patients with chronic hepatitis C resistant to interferon alone. Am J Gastroenterol 2001;96:1143-9.
34. Bresci G, Parisi G, Bertoni M, Scatena F, Capria A. Interferon plus ribavirin in chronic hepatitis C non-responders to recombinant alpha-interferon. J Viral Hepat 2000;7:75-8.
35. Teuber G, Berg T, Hoffmann RM, et al. Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C. Digestion 2000;61:90-7.
36. Salmeron J, Ruiz-Extremera A, Torres C, et al. Interferon versus ribavirin plus interferon in chronic hepatitis C previously resistant to interferon: a randomized trial. Liver 1999;19:275-80.
37. Zuckerman E, Keren D, Slobodin G, et al. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-α. J Rheumatol 2000;27:2172-8.
38. Garini G, Allegri L, Carnevali L, Catellani W, Manganelli P, Buzio C. Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis. Am J Kidney Dis 2001;38:35-9.
39. Calleja JK, Albillos A, Moreno-Otero R, et al. Sustained response to interferon-alpha or to interferon-alpha plus ribavirin in hepatitis C virus-associated symptomatic mixed cryoglobulinemia. Aliment Pharmacol Ther 1999;13:1179-86.
40. Monteverde A, Ballare M, Beroncelli MC, et al: Lymphoproliferation in type II mixed cryoglobulinemia. Clin Exp Rheumatol 1995;13 Suppl 13:141-7.
41. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996;24:289-93.
42. Kaneko S, Unoura M, Kobayashi K, Kuno K, Murakami S, Hattori N. Detection of serum hepatitis C virus RNA [letter]. Lancet 1990;335:976.
43. Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-9.
44. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
45. Efremov DG, Batista FD, Burrone OR. Molecular analysis of IgE heavy chain transcripts expressed in vivo by peripheral blood lymphocytes from normal and atopic individuals. J Immunol 1993;151:2195-207.
46. Franzin F, Efremov DG, Pozzato G, Tulissi P, Batista F, Burrone O. Clonal B-cell expansions in peripheral blood of HCV-infected patients. Br J Haematol 1995;90:548-52.
47. Zorat F, Mazzoran L, Gregorutti M, Baracetti S, Nascimben F, Pozzato G. Retreatment with interferon plus rihavirin in patients affected by chronic hepatitis C [abstract]. J Hepatol 1999;30:244.
48. Baracetti S, Colle R, Gregorutti M, et al. Randomized trial of combination therapy in relapser or non-responder HCV patients [abstract]. J Hepatol 2000;32:107.
49. Norusis MJ. Advanced statistics. SPSS/PC. Chicago: SPSS Inc.; 1986.
50. Davis GL, Esteban-Mur R, Rustgi V, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998;339:1493-9.
51. Reichard O, Norkrans G, Fryden A, Braconier JH, Sonnerborg A, Weiland O. Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. Lancet 1998;351:83-7.
52. Brillanti S, Garson J, Foli M, et al. A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology 1994;107:812-7.
53. Kakumu S, Yoshika K, Tanaka K, et al. Long-term carriage of hepatitis C virus with normal aminotransferase after interferon in patients with chronic hepatitis C. J Med Virol 1993;41:65-70.
54. Colantoni A, De Maria N, Idilman R, Van Thiel DH. Polymerase chain reaction for the detection of HCV-RNA: cryoglobulinemia as a cause of false negative results. It J Hepatol Gastroenterol 1997;29:273-4.
55. Bichard P, Ounanian A, Girard M, Baccard C, Rolachon A, Renversez JC. High prevalence of hepatitis C virus RNA in the supernatant and in the cryoprecipitate of patients with essential and secondary type II mixed cryoglobulinemia. J Hepatol 1994;21:58-63.
56. Mazzaro C, Panarello M, Carniello S, et al. Interferon versus steroids in patients affected by HCV-associated cryoglobulinemic glomerulonephritis. Dig Liver Dis 2000;32:708-15.
57. Mazzaro C, Carniello S, Doretto P, et al. Interferon therapy in HCV-positive mixed cryoglobulinemia: viral and host factors contributing to efficacy of the therapy. It J Gastroenterol Hepatol 1997;29:343-7.
58. Rasul I, Shepherd FA, Kamel-Reid S, Krajden M, Pantalony D, Heathcote EJ. Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. Hepatology 1999;29:543-7.
59. Zignego AL, Giannelli F, Marrocchi ME, et al. T(14;18) translocation in chronic hepatitis C virus infection. Hepatology 2000;31:474-9.
60. Mazzaro C, Franzin F, Tulissi P, et al. Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy. Cancer 1996:77:2604-13.
61. Zuckerman E, Zuckerman T, Sahar D, et al. The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 2001;97:1555-9.
62. Casato M, Mecucci C, Agnello V, et al. Regression of lymphoproliferative disorder after treatment for hepatitis C virus infection in a patient with partial trisomy 3, Bcl-2 overexpression, and type II cryoglobulinemia. Blood 2002;99:2259-61.
63. Donada C, Crucitti A, Donadon V, Chemello L, Alberti A. Interferon and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia [letter]. Blood 1998;92:2983-4.
64. Glue P, Rouzier-Panis R, Raffael C, et al. A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. Hepatology 2000;32:647-53.
65. Lindsay KL, Trepo C, Heintges T, et al. A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C. Hepatology 2001;34:395-403.